Indian scientists identify molecule to help cancer treatment
- Zero-tolerance towards communal violence, must act: Centre to states
- Varanasi: Violence breaks out during protest march, vehicles set ablaze
- Germany our natural partner, says Modi after meeting Merkel; 18 MoUs inked to boost trade
- Why the BJP finds itself in a spot before Gujarat local body polls
- Supreme Court suspends beef ban in Jammu & Kashmir for two months
A team of Indian researchers, led by Dr Sathees C Raghavan of the Indian Institute of Science, Bangalore, have identified a molecule which they claim will revolutionise the cure for cancer. The molecule has been named after "Sathees as SCR7" and a detailed account of it has been carried in the international scientific journal "Cell."
"The discovery could be a major step in improvement of the existing regimens for cancer treatment," Sathees, an Assistant Professor of IISc, told reporters here yesterday. "We hope that this discovery represents a milestone in development of new generation drugs to treat cancer," Sathees, who hails from Kannur district in Kerala, said.
Scientists world over believe that the double-strand break (DSB) of DNA is one of the most lethal form of DNA damage, resulting in drastic consequences such as genome instability, and cancer. DSB is primarily repaired by two pathways, homogeneous recombination and non-homogeneous end joining, which was considered as a major route for the repair of DSBs in humans, he said. The inhibitor SCR7 targets non-homogeneous end joining and offers a strategy towards the treatment of cancer, he said.